Nianyu Li

Amgen (United States)

Papers

1

Total Citations

15

H-Index

1

About

Nianyu Li is a researcher whose work lies at the intersection of high-throughput screening, single-cell analysis, and drug discovery technologies. Li's most notable contribution is the development of an automated system for drug screening that leverages single-cell-multiple functional response technology, a sophisticated approach that integrates semiautomated sample preparation, high-speed sample collection, and innovative analytical tools capable of delivering instantaneous results across compound dilutions in 384-well formats. This work, published in 2013 and accumulating 15 citations, represents a meaningful advance in secondary screening methodologies, enabling researchers to interrogate biological responses at an unprecedented resolution — the individual cell level. By pushing screening capabilities to the single-cell scale, Li's research addresses a critical bottleneck in pharmaceutical development, where population-averaged measurements can obscure important cellular heterogeneity. This contribution has practical implications for improving the precision and efficiency of early-stage drug discovery pipelines. Li's work appeals to researchers in pharmacology, bioanalytical chemistry, and systems biology who seek more nuanced, high-resolution tools for understanding how compounds interact with biological systems at their most fundamental unit.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
High-Throughput Secondary Screening at the Single-Cell Level
15 citations · 2013
📈 Most Prolific Year: 2013 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: Amgen (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago